The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Human Papilloma Virus-Associated Cervical Cancer and Health Disparities
Open accessAbstract
Cervical cancer develops through persistent infection with high-risk human papilloma virus (hrHPV) and is a leading cause of death among women worldwide and in the United States. Periodic surveillance through hrHPV and Pap smear-based testing has remarkably reduced cervical cancer incidence worldwide and in the USA. However, considerable discordance in the occurrence and outcome of cervical cancer in various populations exists. Lack of adequate health insurance appears to act as a major socioeconomic burden for obtaining cervical cancer preventive screening in a timely manner, which results in disparate cervical cancer incidence. On the other hand, cervical cancer is aggressive and often detected in advanced stages, including African American and Hispanic/Latina women. In this context, our knowledge of the underlying molecular mechanism and genetic basis behind the disparate cervical cancer outcome is limited. In this review, we shed light on our current understanding and knowledge of racially disparate outcomes in cervical cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Fu, F., Wang, T., Wu, Z., Feng, Y., Wang, W., Zhou, S., Ma, X., & Wang, S. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0683-x · Cited by 87
RetractedLi, J., Chen, Q., Liu, X., Li, C., Chen, J., & Shi, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-28906-9 · Cited by 16
RetractedHuman papillomavirus and cervical cancer
Burd, E. M. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.1.1-17.2003 · Cited by 2,420
Improved Survival with Bevacizumab in Advanced Cervical Cancer
Tewari, K. S., Sill, M. W., Long, H. J., Penson, R. T., Huang, H., Ramondetta, L. M., Landrum, L. M., Oaknin, A., Reid, T. J., Leitao, M. M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1309748 · Cited by 1,504
Integrated genomic and molecular characterization of cervical cancer
The Cancer Genome Atlas Research Network (2017) · Nature · doi:10.1038/nature21386 · Cited by 1,479
Human papillomavirus and cervical cancer
Crosbie, E. J., Einstein, M. H., Franceschi, S., & Kitchener, H. C. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60022-7 · Cited by 1,171
Petrosky, E. Y., Bocchini, J. A., Hariri, S., Chesson, H. W., Curtis, C. R., Saraiya, M., Unger, E. R., & Markowitz, L. E. (2015) · PubMed · Cited by 1,047
HPV vaccines – A review of the first decade
Harper, D. M., & DeMars, L. R. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.04.004 · Cited by 429
Haffner, M. C., Chaux, A., Meeker, A. K., Esopi, D. M., Gerber, J., Pellakuru, L. G., Toubaji, A., Argani, P., Iacobuzio-Donahue, C., Nelson, W. G., et al. (2011) · Oncotarget · doi:10.18632/oncotarget.316 · Cited by 423
Maldonado, L., Teague, J. E., Morrow, M. P., Jotova, I., Wu, T. C., Wang, C., Desmarais, C., Boyer, J. D., Tycko, B., Robins, H. S., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007323 · Cited by 255
Cervical Cancer Screening Barriers and Risk Factor Knowledge Among Uninsured Women
Akinlotan, M., Bolin, J. N., Helduser, J., Ojinnaka, C., Lichorad, A., & McClellan, D. (2017) · Journal of Community Health · doi:10.1007/s10900-017-0316-9 · Cited by 223
Cancer prevention and screening: the next step in the era of precision medicine
Loomans-Kropp, H. A., & Umar, A. (2019) · npj Precision Oncology · doi:10.1038/s41698-018-0075-9 · Cited by 205
Ten Years of Human Papillomavirus Vaccination in the United States
Markowitz, L. E., Gee, J., Chesson, H., & Stokley, S. (2018) · Academic Pediatrics · doi:10.1016/j.acap.2017.09.014 · Cited by 203
Mitochondrial Cytochrome B Gene Mutation Promotes Tumor Growth in Bladder Cancer
Dasgupta, S., Hoque, M. O., Upadhyay, S. K., & Sidransky, D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5532 · Cited by 137
Self-citationDraper, E., Bissett, S. L., Howell‐Jones, R., Waight, P., Soldan, K., Jit, M., Andrews, N., Miller, E., & Beddows, S. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061825 · Cited by 133
HPV Vaccination for the Prevention of Cervical Intraepithelial Neoplasia
Kahn, J. A. (2009) · New England Journal of Medicine · doi:10.1056/nejmct0806938 · Cited by 129
Cervical-Cancer Screening with Human Papillomavirus and Cytologic Cotesting
SCHIFFMAN, M. H., & Solomon, D. (2013) · New England Journal of Medicine · doi:10.1056/nejmcp1210379 · Cited by 125
Bierkens, M., Hesselink, A. T., Meijer, C. J. L. M., Heideman, D. A. M., Wisman, G. B. A., van der Zee, A. G. J., Snijders, P. J. F., & Steenbergen, R. D. M. (2013) · International Journal of Cancer · doi:10.1002/ijc.28138 · Cited by 117
Epigenetic alterations in preneoplastic and neoplastic lesions of the cervix
Saavedra, K., Brebi, P., & Roa, J. C. (2012) · Clinical Epigenetics · doi:10.1186/1868-7083-4-13 · Cited by 110
New clinical trial designs in the era of precision medicine
Garralda, E., Dienstmann, R., Piris‐Giménez, A., Braña, I., Rodon, J. A., & Tabernero, J. M. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12465 · Cited by 110
Too many women are dying from cervix cancer: Problems and solutions
Gaffney, D. K., Hashibe, M., Kepka, D., Maurer, K. A., & Werner, T. L. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.10.004 · Cited by 104
Saving the World’s Women from Cervical Cancer
Tsu, V. D., & Jerónimo, J. (2016) · New England Journal of Medicine · doi:10.1056/nejmp1604113 · Cited by 99
Prevention of Invasive Cervical Cancer in the United States: Past, Present, and Future
Pierce Campbell, C. M., Menezes, L. J., Paskett, E. D., & Giuliano, A. R. (2012) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-1158 · Cited by 95
The Landscape of mtDNA Modifications in Cancer: A Tale of Two Cities
Hertweck, K. L., & Dasgupta, S. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00262 · Cited by 94
Self-citationRees, I., Jones, D., Chen, H., & Macleod, U. (2018) · Preventive Medicine · doi:10.1016/j.ypmed.2017.11.019 · Cited by 92
Dasgupta, S., Soudry, E., Mukhopadhyay, N. D., Shao, C., Yee, J., Lam, S., Lam, W. L., Zhang, W. Y., Gazdar, A. F., Fisher, P. B., et al. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22980 · Cited by 92
Self-citationYao, S., Xu, J., Zhao, K., Song, P., Yan, Q., Fan, W., Wan, L., & Lu, C. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1059-y · Cited by 82
Role of Immunotherapy in the Management of Locally Advanced and Recurrent/Metastatic Cervical Cancer
Dyer, B. A., Zamarin, D., Eskandar, R. N., & Mayadev, J. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.7108 · Cited by 78
Ethnic density and cancer: A review of the evidence
Fang, C. Y., & Tseng, M. (2018) · Cancer · doi:10.1002/cncr.31177 · Cited by 74
PD-1/PD-L1 immune checkpoint inhibitors in advanced cervical cancer
Saglam, O., & Conejo-Garcia, J. R. (2018) · Integrative Cancer Science and Therapeutics · doi:10.15761/icst.1000272 · Cited by 71
Ma, D., Chang, L.-Y., Zhao, S., Zhao, J., Xiong, Y., Cao, F.-Y., Lu, Y., Zhang, Q., Wang, X., Geng, M.-L., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-15979-1 · Cited by 70
Targeting Cyclin-Dependent Kinases for Treatment of Gynecologic Cancers
Lin, Z. P., Zhu, Y.-L., & Ratner, E. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00303 · Cited by 68
ADXS-HPV: A therapeuticListeriavaccination targeting cervical cancers expressing the HPV E7 antigen
Cory, L. A., & Chu, C. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.34378 · Cited by 66
Increasing Cervical Cancer Screening Among US Hispanics/Latinas: A Qualitative Systematic Review
Mann‐Jackson, L., Foley, K. L., Tanner, A. E., Sun, C. J., & Rhodes, S. D. (2014) · Journal of Cancer Education · doi:10.1007/s13187-014-0716-9 · Cited by 64
Su, Y., Xiong, J., Hu, J., Wei, X., Zhang, X., & Rao, L. (2016) · Oncotarget · doi:10.18632/oncotarget.11722 · Cited by 62
Dang, E., Yang, S., Song, C., Jiang, D., Li, Z., Fan, W., Sun, Y., Tao, L., Wang, J., Wang, J., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0824-2 · Cited by 60
Race and Ethnic Disparities in Cervical Cancer Screening in a Safety-Net System
Owusu, G. A., Eve, S. B., Cready, C. M., Koelln, K., Treviño, F. M., Urrutia‐Rojas, X., & Baumer, J. (2005) · Maternal and Child Health Journal · doi:10.1007/s10995-005-0004-8 · Cited by 58
A Social-Ecological Review of Cancer Disparities in Kentucky
Rodriguez, S. D., Vanderford, N. L., Huang, B., & Vanderpool, R. C. (2018) · Southern Medical Journal · doi:10.14423/smj.0000000000000794 · Cited by 51
From HPV Infection to Lesion Progression: The Role of HLA Alleles and Host Immunity
Paaso, A., Jaakola, A., Syrjänen, S., & Louvanto, K. (2019) · Acta Cytologica · doi:10.1159/000494985 · Cited by 50
Mitochondrial DNA variation analysis in cervical cancer
Kabekkodu, S. P., Bhat, S., Mascarenhas, R., Mallya, S. P., Bhat, M. K., Pandey, D., Kushtagi, P., Kumarasamy Thangaraj, K., Gopinath, P. M., & Satyamoorthy, K. (2013) · Mitochondrion · doi:10.1016/j.mito.2013.07.001 · Cited by 44
miR-27a inhibits cervical adenocarcinoma progression by downregulating the TGF-βRI signaling pathway
Fang, F., Huang, B., Sun, S., Xiao, M., Guo, J., Yi, X., Cai, J., & Wang, Z. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0431-2 · Cited by 40
Warowicka, A., Kwaśniewska, A., & Gozdzicka-Jozefiak, A. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.01.001 · Cited by 39
Cancer in the Medically Underserved Population
Olaku, O. O., & Taylor, E. A. (2017) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2016.09.020 · Cited by 35
Heintzman, J. D., Hatch, B., Coronado, G. D., Ezekiel-Herrera, D., Cowburn, S., Escamilla-Sanchez, O., & Marino, M. (2018) · Preventing Chronic Disease · doi:10.5888/pcd15.170267 · Cited by 34
Kuguyo, O., Tsikai, N., Thomford, N. E., Magwali, T. L., Madziyire, M. G., Nhachi, C. F. B., Matimba, A., & Dandara, C. (2018) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2018.0075 · Cited by 34
A prospective study of risk-based colposcopy demonstrates improved detection of cervical precancers
Wentzensen, N., Walker, J. L., Smith, K., Gold, M. A., Zuna, R. E., Massad, L. S., Liu, A. H.-C., Silver, M. I., Dunn, S. T., & SCHIFFMAN, M. H. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.02.009 · Cited by 32
Cues to Cervical Cancer Screening Among U.S. Hispanic Women
de Peralta, A. M., Holaday, B. J., & Hadoto, I. M. (2016) · Hispanic Health Care International · doi:10.1177/1540415316682494 · Cited by 30
Making HPV vaccination available to girls everywhere
Oberlin, A. M., Rahangdale, L., Chinula, L., Fuseini, N. M., & Chibwesha, C. J. (2018) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12656 · Cited by 30
Intratumor chromosomal heterogeneity in advanced carcinomas of the uterine cervix
Lyng, H., Beigi, M., Svendsrud, D. H., Brustugun, O. T., Stokke, T., Kristensen, G. B., Sundfør, K., Skjønsberg, A., & Angelis, P. M. D. (2004) · International Journal of Cancer · doi:10.1002/ijc.20258 · Cited by 27
Khan, H. M. R., Gabbidon, K., Saxena, A., Abdool-Ghany, F., Dodge, J. M., & Lenzmeier, T. (2016) · Journal of Women s Health · doi:10.1089/jwh.2015.5585 · Cited by 24
Performance of CADM1/MAL-methylation analysis for monitoring of women treated for high-grade CIN
Uijterwaal, M. H., van Zummeren, M., Kocken, M., Luttmer, R., Berkhof, J. H., Lissenberg-Witte, B. I., van Baal, W. M., Graziosi, G. C. M., Verheijen, R. H. M., Helmerhorst, T. J. M., et al. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.07.089 · Cited by 24
Kim, M., Lee, I.-H., Lee, K., Lee, Y., So, K. A., Hong, S. R., Hwang, C.-S., Kee, M., Rhee, J. E., Kang, C., et al. (2015) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2016.27.e14 · Cited by 22
Mutational analysis of uterine cervical cancer that survived multiple rounds of radiotherapy
Nuryadi, E., Sasaki, Y., Hagiwara, Y., Permata, T. B. M., Sato, H., Komatsu, S., Yoshimoto, Y., Murata, K., Ando, K., Kubo, N., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25982 · Cited by 20
Sakane, J., Taniyama, K., Miyamoto, K., Saito, A., Kuraoka, K., 西村, 俊., Sentani, K., Oue, N., & Yasui, W. (2015) · Diagnostic Cytopathology · doi:10.1002/dc.23256 · Cited by 19
Health Disparities between Black Hispanic and Black Non-Hispanic Cervical Cancer Cases in the USA
Khan, H. M. R., Gabbidon, K., Abdool-Ghany, F., Saxena, A., Gomez, E., & Stewart, T. S.-J. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.22.9719 · Cited by 19
Disparities in Cervical Cancer Incidence and Mortality
Maguire, R. L., Vidal, A. C., Murphy, S. K., & Hoyo, C. (2016) · Advances in cancer research · doi:10.1016/bs.acr.2016.09.001 · Cited by 19
Mitochondrial DNA mutations in patients with HRHPV-related cervical lesions.
Goia-Ruşanu, C. D., Iancu, I. V., Botezatu, A., Socolov, D. G., Huică, I., Pleşa, A., & Anton, G. (2011) · PubMed · Cited by 17
Greene, M. Z., Meghani, S. H., Sommers, M. S., & Hughes, T. L. (2018) · Journal of Midwifery & Women s Health · doi:10.1111/jmwh.12872 · Cited by 17
Ge, Y., Christensen, P. A., Luna, E., Armylagos, D., Xu, J., Schwartz, M. R., & Mody, D. R. (2019) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2018-000024 · Cited by 14
Cited by
Bukowski, A., Hoyo, C., Hudgens, M. G., Brewster, W. R., Valea, F., Bentley, R. C., Vidal, A. C., Maguire, R. L., Schmitt, J. W., Murphy, S. K., et al. (2022) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-22-0054 · Cited by 9
Metadata
- Authors
- Olusola, P., Banerjee, H. N., Philley, J. V., & Dasgupta, S.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2019-06-21
- Volume
- 8
- Issue
- 6
- Pages
- 622
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W2951056855
- Cited by
- 392
- References
- 59
- FWCI
- 25.17
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.